Wockhardt：Zaynich ™ (Zidebactam and Cefepime)was approved
Shionogi：XOCOVA® (ensitrelvir)was approved for marketing in the United States.
J&J：Complete data for Nipocalimab were announced.
Roche：Tecentriq®Atezolizumab was submitted for marketing approval in the U.S. and granted Priority Review designation.
Sanofi：TZIELD®teplizumab Gets U.S. Label Expansion Approval
AstraZeneca：TRUQAP®Capivasertib was approved for marketing in the United States.
Biokin：BL-B01D1 has initiated its 13th Phase III clinical trial.
Trinomab：The IPO registration has become effective.
CSPC：SYH2095 has received its first clinical trial approval.
CSPC：SYS6051 has received its first clinical trial approval.